- Home
- DNLI vs CORT Comparison
DNLI vs CORT Comparison
Compare DNLI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- CORT
- Stock Information
- Founded
- DNLI 2013
- CORT 1998
- Country
- DNLI United States
- CORT United States
- Employees
- DNLI N/A
- CORT N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- DNLI Health Care
- CORT Health Care
- Exchange
- DNLI Nasdaq
- CORT Nasdaq
- Market Cap
- DNLI 3.3B
- CORT 5.9B
- IPO Year
- DNLI 2017
- CORT N/A
- Fundamental
- Price
- DNLI $20.84
- CORT $49.97
- Analyst Decision
- DNLI Strong Buy
- CORT Strong Buy
- Analyst Count
- DNLI 11
- CORT 4
- Target Price
- DNLI $40.40
- CORT $75.25
- AVG Volume (30 Days)
- DNLI 867.7K
- CORT 834.4K
- Earning Date
- DNLI 02-25-2025
- CORT 02-13-2025
- Dividend Yield
- DNLI N/A
- CORT N/A
- EPS Growth
- DNLI N/A
- CORT 57.97
- EPS
- DNLI N/A
- CORT 1.26
- Revenue
- DNLI N/A
- CORT $628,555,000.00
- Revenue This Year
- DNLI N/A
- CORT $46.29
- Revenue Next Year
- DNLI $420.35
- CORT $17.09
- P/E Ratio
- DNLI N/A
- CORT $39.64
- Revenue Growth
- DNLI 204.74
- CORT 39.67
- 52 Week Low
- DNLI $14.56
- CORT $20.84
- 52 Week High
- DNLI $33.33
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- DNLI 35.14
- CORT 36.96
- Support Level
- DNLI $19.93
- CORT $49.51
- Resistance Level
- DNLI $21.64
- CORT $53.67
- Average True Range (ATR)
- DNLI 0.96
- CORT 2.56
- MACD
- DNLI -0.06
- CORT -0.68
- Stochastic Oscillator
- DNLI 21.56
- CORT 5.24
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.